Ó£»¨ÊÓƵ

Skip to main content

Table 3 Uptake of COVID-19 vaccination among persons living with diabetes mellitus

From: Factors associated with full COVID-19 vaccination among persons living with diabetes mellitus in Uganda–A cross-sectional study

Variable

N

%

Full vaccination status(≥ 2 doses or 1 dose for the J&J)

ÌýÌý

Fully vaccinated

195

57.35

Partially vaccinated

27

7.94

Not vaccinated

118

34.7

Vaccines received(among those with ≥ 1 dose)

ÌýÌý

Oxford-AstraZeneca only

82

36.94

J & J’s Janssen Only

37

16.67

Pfizer only

46

20.72

Oxford-AstraZeneca and Pfizer

41

18.47

J & J’s Janssen and Oxford-AstraZeneca

6

2.7

Oxford-AstraZeneca and Covaxin

1

0.45

Convidicea and Oxford-AstraZeneca

1

0.45

Pfizer and J & J’s Janssen

8

3.60